Fake Paper Exposes Failed Peer Review

The widespread acceptance of an atrocious manuscript, fabricated by an investigative journalist, reveals the near absence of quality at some journals.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, SCREAMING_MONKEYHaving an authentic name, representing a real research institution, and offering actual scientific results are apparently not required for publication in many open access journals, Science has found. A completely invented scientist—“Ocorrafoo Cobange”—who worked at a fabricated institution—“the Wassee Institute of Medicine in Asmara”—was able to get the same terribly faked paper accepted for publication in 157 journals. “My hope is that now that we have a map of at least some of the good versus bad journals, scientists can submit their paper to one of the good guys and for the same amount of money get the real deal,” John Bohannon, the Science correspondent who did the investigation, told NPR.

Many of the journals were already flagged by Beall's List, which catalogs questionable publications, but others were present in the Directory of Open Access Journals, which aims to list credible publications. One example Bohannon highlighted in his report was a journal published by Sage, which was named “the Independent Publishers Guild Academic and Professional Publisher of the Year” in 2012. “The Sage publication that accepted my bogus paper is the Journal of International Medical Research. Without asking for any changes to the paper's scientific content, the journal sent an acceptance letter and an invoice for $3,100,” Bohannon wrote.

Bohannon's article details what others have also found: that open-access publishers have varied standards. But some have criticized the investigation as hostile toward open access, given that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform